Market Overview The Japan Anticoagulation Market is advancing as cancer-associated thrombosis management advances in Japanese oncology practice. The Japan Anticoagulation Market is projected to grow through 2030, driven by increasing cancer incidence in aging population, growing recognition of VTE as leading cause of cancer mortality, rising complexity of anticoagulation in thrombocytopenic...